The Role of Sulopenem in the Treatment of Uncomplicated Urinary Tract Infections: A Systematic Review and Meta-Analysis
Abstract
Uncomplicated urinary tract infections (uUTIs) rank as one of the most frequent bacterial infections, particularly in females, and antimicrobial resistance is complicating the situation more and more. So, first-line agents such as nitrofurantoin and trimethoprim-sulfamethoxazole are losing their beneficial effects. There is an urgent call for new therapies due to the very alarming global rise of extended-spectrum β-lactamase-producing bacterial isolates. Sulopenem is a new antibiotic of the penem series available for both intravenous and oral administration, a potential candidate against multidrug-resistant Gram-negative organisms. It offers anti-β-lactamase stability, oral activity, and possible hospitalization duration reduction, hence, making it the best option for consideration. This article conducts a review of the evidence surrounding sulopenem regarding efficacy, safety, and resistance mechanisms. According to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, clinical trials were searched in databases, including PubMed, Scopus, Embase, Medline, and the Cochrane Library. Five studies were selected that include randomized trials, comparative effectiveness research, and pharmacokinetic/pharmacodynamic (PK/PD) modeling studies. Main outcomes were microbiological cure, resolution of symptoms, recurrence of clinical symptoms, and adverse events. Sulopenem was either non-inferior or superior to comparators in important subgroups.…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.